CYP 3.85% 25.0¢ cynata therapeutics limited

Ann: June 2019 Quarterly Report, page-6

  1. 174 Posts.
    lightbulb Created with Sketch. 85
    Wouldn’t say WARF has dug it’s heels in, they want to commercialise, not make it more difficult? Another way to read it; Fuji are making sure the structural setup is going to work for them when they own CYP, not just for a single license.
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.